Tissue microarray analysis reveals protein expression patterns and potential biomarkers of clinical benefit to bortezomib in relapsed/refractory non-Hodgkin lymphoma

John Gerecitano, Sivaraman Gounder, Julie Teruya-Feldstein, Maria Arcila, Shahiba Ogilvie, Camille Gonzalez, Dorothy Lin, Junting Zheng, Zhigang Zhang, Alice McDonald, George Mulligan, Owen A. O'Connor

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)290-292
Number of pages3
JournalBritish Journal of Haematology
Issue number2
StatePublished - Jul 2012
Externally publishedYes


  • Bortezomib
  • CDKN1B
  • MCL1
  • Non-Hodgkin lymphoma
  • Tissue microarray

Cite this